🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 89853L104
- Market Cap
- Small Cap
- IPO
- 8/6/2014 · $11.00/share
Business: T2 Biosystems, Inc. is an in vitro diagnostics company that has developed an innovative and proprietary technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company is using its T2 Magnetic Resonance platform, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier.
Company Contact
- CEO
- John Sperzel
- CFO
- John M. Sprague
- Headquarters
- 101 Hartwell Avenue, Lexington, MA 02421
- Phone
- 781-457-1200
- Fax
- 781-357-3080
- Investor Relations
- Philip Trip Taylor, Gilmartin Group · 415-937-5406 · philip@gilmartinIR.com